|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (3Y Monthly)||4.05|
|PE Ratio (TTM)||113.70|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Prospective investors in cannabis companies like Aphria Inc (OTC: APHQF), Aurora Cannabis Inc (OTC: ACBFF) and Cronos Group Inc (NASDAQ: CRON) should take another metric into account: the companies' Latin American presence. A new report from Prohibition Partners shows that the Latin American cannabis market could reach a value of $12 billion within the next decade. Latin America has a population of over 650 million, but the continent's total health care costs are around $354 billion — significantly smaller than Europe, which has a population of 740 million and health care spending of more than $2.6 trillion.
Cannabis will be legal in Canada starting this Wednesday, generating strong interest from investors eager to get in on a market that analysts and experts expect to be worth billions of dollars.
HENDERSON, NV / ACCESSWIRE / October 15, 2018 / A fascinating biotechnology firm PPCB (Propanc Biopharma, Inc.) erupted for over 7000% in the between late August and early September going from a low of $0.0039 to a high of over $0.28, the stock is still holding a substantial gain of 1795% as of the close on Friday. PPCB may start receiving increased attention from the street at any moment. PPCB has a 52 week high of $0.77.
LEAMINGTON, ON , Oct. 15, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has completed its first shipment of cannabis oil to its Argentina -based subsidiary ABP, S.A. ("ABP" or the "Argentinean Company"), a pharmaceutical import and distribution company. In accordance with a previously announced supply agreement, the Company delivered 1,500 bottles of Aphria's renowned Rideau CBD oil, which were provided to Hospital de Pediatria Garrahan ("Hospital Garrahan" or the "Hospital"), a leading pediatric hospital located in Buenos Aires , for use in a clinical study focused on treating refractory epilepsy in children.
In just days, the entire country of Canada will allow recreational cannabis to be legally sold across the nation. This event also has a number of companies outside of the cannabisspace showing interest and getting involved. "The total global [cannabis] category could reach upwards of $200 billion, as suggested by Constellation Brands," said Stifel analyst Christopher Growe.
In the news release, Aphria Records Solid Revenue Growth in First Quarter of 2019, issued 12-Oct-2018 by Aphria Inc. over Cision, we are advised by the company that the increase in revenue YOY should be 117% rather than 217% as originally issued inadvertently. LEAMINGTON, ON , Oct. 12, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or US OTC: APHQF) today reported its results, for the first quarter and quarter ended August 31, 2018 .
NEW YORK, NY / ACCESSWIRE / October 12, 2018 / Aphria Inc (OTCQB: APHQF ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on October 12, 2018 at 9:00 AM Eastern ...
Marijuana stocks were mostly lower Thursday, with a key sector tracker falling into correction territory, but MedMen Enterprises Inc. was a standout gainer after the company announced a $682 million acquisition of U.S.-based medical cannabis dispensary PharmaCann LLC.
CORAL GABLES, FL / ACCESSWIRE / October 11, 2018 / Thecannabis industry is seeing the birth of strategic investments and new acquisitions this year. Ahead of Canada's national legalization of recreationalmarijuana next week, investors are laser focused on marijuana stocks. "With cannabis, you're talking about this massive step change in terms of the addressable market," Vivien Azer said on CNBC's "Squawk Box" on Wednesday.
HENDERSON, NV / ACCESSWIRE / October 11, 2018 / With the broader market tanking it is likely investors will find safe haven in cannabis and biotech stocks because they are both innovative sectors. An incredibly ...
On October 10, Reuters reported that tobacco giant Altria is in discussions with Aphria (APHQF) about acquiring a stake in the company. The initial round of investments would give Altria a minority stake in Aphria with the possibility of acquiring a majority stake. Following the news, Aphria stock gained 15.2% to close the day at 20.1 Canadian dollars as investors rushed to capitalize on the opportunity.
On October 9, Canopy Growth (CGC) (WEED) announced that it has completed a legal transfer of medical cannabis to the United States for the sole purpose of research related to medical product development. Canopy Growth is the second company to do so after Tilray (TLRY) announced last month that it received approval from US regulators to export its cannabis products for medical research.
The cannabis sector was largely in positive territory on October 10 when the overall market experienced a heavy sell-off sparked by technology stocks. The Horizons Marijuana Life Sciences ETF (HMMJ) gained 1% during the day, and the Emerging Marijuana Growers Index ETF (HMJR) was ~79 basis points higher.
NEW YORK, NY / ACCESSWIRE / October 11, 2018 / U.S. equities continued to tumble on Wednesday on rising yields and interest rates. Additionally, weakening tech stocks pressured the S&P 500 to its worst ...
LEAMINGTON, ON , Oct. 11, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH) (OTCQB: APHQF) and Drug Free Kids Canada ("Drug Free Kids" or "DFK") announced today that they have entered into a Charter Agreement (the "Agreement") focused on increasing educational awareness of the potential harms of cannabis for children and underage youth and the safe and responsible use of cannabis by adults. Aphria and Drug Free Kids are united by their shared values of keeping cannabis out of the hands of children and youth and raising awareness though effective educational campaigns. "As a leading global cannabis company, Aphria has consistently advocated for an education-led approach to keeping cannabis out of the hands of youth, while promoting the safe and responsible use of legal cannabis by adults," said Tamara Macgregor , Vice President of Communications for Aphria.
Marlboro maker Altria Group Inc. is in talks with Canada-based cannabis producer Aphria Inc. to potentially acquire an equity stake in the company, The Globe and Mail reported Wednesday. Aphria stock rose 14.1%. The Globe, a subscription news site, citing multiple anonymous sources, said Altria was interested in a minority stake in Aphria with the intention of acquiring a majority stake in the longer run, but the deal terms are not final. Altria and Aphria's leadership teams have met on several occasions, with the most recent talks on Monday, the Globe said, again citing anonymous sources. After the market closed, Aphria issued a statement about the report. "While Aphria engages in discussions with potential strategic partners and/or investors from time to time, the company notes that there is no agreement, understanding or arrangement in place with a potential investor at this time," the statement reads. "Aphria will advise the investment community of any material changes, if and when they occur, in accordance with applicable disclosure requirements." Aphria stock is up 1.4% this year, including Wednesday's midday gains. The S&P 500 index has gained 5.4% this year.
LEAMINGTON, ON , Oct. 10, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) today responded to a request from the Investment Industry Regulatory Organization of Canada ("IIROC") regarding media reports suggesting the Company is engaged in discussions regarding a potential investment in Aphria. While Aphria engages in discussions with potential strategic partners and/or investors from time to time, the Company notes that there is no agreement, understanding or arrangement in place with a potential investor at this time. Aphria will advise the investment community of any material changes, if and when they occur, in accordance with applicable disclosure requirements.
Aurora Cannabis (OTCMKTS:ACBFF) just announced that it applied to list on the New York Stock Exchange. The Edmonton, Alberta-based medical marijuana firm would follow its peer Canopy Growth (NYSE:CGC) in switching to the NYSE. With the company more open to U.S. investors and legalization in Canada, ACBFF stock could see a short-term bump.
HENDERSON, NV / ACCESSWIRE / October 10, 2018 / There have been some very intriguing news, and public filings recently for some otc companies. Public filings and news releases can shed light on very important ...
On October 9, Namaste, a licensed cannabis producer in Canada, was caught right in the middle of yet another controversy related to litigation against the company. The company specifically called out Citron Research for publishing false reports about litigation against Namaste. On September 24, Namaste was caught in another controversy that led Tilray to sever ties with the company.
Astute investors with experience recognize that while some will make millions by investing in marijuana stocks, most will lose their shirts. This makes sense because of high volatility, stock prices being divorced from fundamentals, pump-and-dump schemes, trading based on sentiment and short-squeezes and occasional frauds. Please see “How to potentially become a marijuana millionaire, albeit carefully.” Investors have been asking me: If I could buy only one marijuana stock, what would it be?
NEW YORK, NY / ACCESSWIRE / October 8, 2018 / U.S. equities plunged on Friday as concerns over rising interest rates countered upbeat economic data. U.S. unemployment rate dropped to 3.7 percent, its lowest ...